Why monoclonal antibodies might signal the end of generic drugs
I just recently came to the realization that the most profitable drugs right now are monoclonal antibodies and how they are essentially impossible to make a generic version of.
https://www.statista.com/statistics/2...
https://jbiomedsci.biomedcentral.com/...